Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil.

In the past few years there has been increasing concern about the transmission of drug-resistant HIV. This study aimed to describe the frequency of primary mutations associated with HIV-1 drug resistance and the prevalence of genetic HIV subtypes in a population of vertically infected children before the initiation of HAART. At the time of genotypic testing, the median age was 6.0 years (IQR 25-75%: 3.8-9.2) and the median age at admission was 3.84 years (IQR 25-75%: 1.23-6.11). Antepartum maternal ARV exposure for PMTCT occurred for three (7.3%) mothers. According to the WHO criteria, primary ARV resistance mutations were detected in four out of 41 (9.8%) children. Subtype B was the most prevalent (63.4%). The relatively high prevalence of primary HIV-1 DRMs in this cohort of perinatally infected children in Brazil supports the local recommendation to perform resistance testing in all newly diagnosed children, regardless of age at diagnosis and antenatal ARV exposure.

[1]  R. Rodrigues,et al.  Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children. , 2009, Jornal de pediatria.

[2]  R. Paranjape,et al.  Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India. , 2008, AIDS research and human retroviruses.

[3]  A. Mocroft,et al.  Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study , 2008, Journal of acquired immune deficiency syndromes.

[4]  V. Melo,et al.  Determinants and trends in perinatal human immunodeficiency virus type 1 (HIV-1) transmission in the metropolitan area of Belo Horizonte, Brazil: 1998 - 2005. , 2008, Memorias do Instituto Oswaldo Cruz.

[5]  Ryan J Coller,et al.  ANTIBODY RESPONSE TO HEPATITIS A IMMUNIZATION AMONG HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND ADOLESCENTS , 2008, The Pediatric infectious disease journal.

[6]  Soo-Yon Rhee,et al.  Consensus Drug Resistance Mutations for Epidemiological Surveillance: Basic Principles and Potential Controversies , 2008, Antiviral therapy.

[7]  C. Barreto,et al.  Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city. , 2007, Virus research.

[8]  H. Salomón,et al.  High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children , 2007, Antiviral therapy.

[9]  J. Drexler,et al.  High prevalence of primary antiretroviral resistance among HIV-1-infected adults and children in Bahia, a northeast state of Brazil. , 2007, Journal of acquired immune deficiency syndromes.

[10]  A. Geretti,et al.  Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. , 2007, The Journal of antimicrobial chemotherapy.

[11]  A. Phillips,et al.  Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection. , 2007, The Journal of antimicrobial chemotherapy.

[12]  Soo-Yon Rhee,et al.  HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance , 2007, AIDS.

[13]  H. R. Lacerda,et al.  Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil. , 2006, Memorias do Instituto Oswaldo Cruz.